ABH Healthcare IPO Day 2 Live: QIB jumps 142% to 8.37x; Check details
- ABH Healthcare IPO QIB subscription surged 142.6% to 8.37x on Day 2.
- Overall subscription stands at 0.76x, with retail participation lagging at 0.49x.
- The company operates a 150-bed hospital in Ferozepur, Punjab, with ₹52.51 crore revenue in FY 2026.
- Key risks include geographic concentration and a high debt-to-equity ratio of 3.20.
*this image is generated using AI for illustrative purposes only.
ABH Healthcare’s public issue witnessed a dramatic shift in momentum on Day 2, with Qualified Institutional Buyers (QIBs) racing ahead to book an 8.37x subscription. The overall offer has been subscribed 0.76x so far, driven almost entirely by institutional demand.
Subscription Status
The QIB category led the charge, jumping from 3.45x on Day 1 to 8.37x by mid-day on August 25. This represents a massive 142.6% increase in just a few hours. In contrast, individual investor categories remained sluggish. Retail subscription ticked up marginally to 0.49x, while Non-Institutional Buyers (NII) recorded a combined 0.10x (0.09x for sHNI and 0.01x for bHNI).
| Category | Day 1 (24-08-2026) | Day 2 (25-08-2026) |
|---|---|---|
| QIB | 3.45x | 8.37x |
| NII (bHNI) | 0.07x | 0.01x |
| NII (sHNI) | 0.01x | 0.09x |
| Retail | 0.31x | 0.49x |
| Total | 0.37x | 0.76x |
Intra-day timeline on 25-08-2026
Subscription figures remained static in the early hours before QIBs entered the fray aggressively around noon.
| Time (IST) | QIB | NII (bHNI) | Retail | Total |
|---|---|---|---|---|
| 11:15 | 3.45x | 0.08x | 0.46x | 0.44x |
| 12:15 | 8.37x | 0.09x | 0.49x | 0.76x |
About the Company
ABH Healthcare Limited operates a 150-bed multi-specialty tertiary care hospital under the "Anil Baghi Hospital" brand in Ferozepur, Punjab. Founded in 2021 and acquiring the hospital business in 2022, the company provides specialized healthcare services across 25 medical specialties. The facility is led by U.S.-trained doctors and is empaneled with over 30 insurance companies and government schemes like Ayushman Bharat.
Financial Highlights
The company has demonstrated growth in revenue and profitability over the last three fiscal years.
| Particulars | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|
| Revenue from Operations (₹ crores) | 41.38 | 49.27 | 52.51 |
| Profit After Tax (₹ crores) | 1.66 | 5.35 | 5.64 |
| Total Equity (₹ crores) | 6.35 | 11.69 | 17.34 |
Revenue grew from ₹41.38 crores in FY 2024 to ₹52.51 crores in FY 2026. PAT increased significantly from ₹1.66 crores to ₹5.64 crores over the same period.
Objects of the Issue
The net proceeds from the IPO will be utilized for:
- Repayment/prepayment of certain borrowings: ₹17.00 crores
- Funding working capital requirements: ₹5.00 crores
- Funding inorganic growth through unidentified acquisitions and general corporate purposes
Risk Factors
- Limited operating history as a company since incorporation in March 2021.
- Geographic revenue concentration risk with 100% revenue from its single hospital in Ferozepur.
- High debt-to-equity ratio of 3.20 in Fiscal 2026, posing funding risks.
Key Dates
- Issue Open Date: 24-08-2026
- Issue Close Date: 27-08-2026
- Allotment Date: 28-08-2026
- Listing Date: 01-09-2026
Will the significant disparity between QIB oversubscription and sluggish retail interest impact the final listing price and initial trading volatility?
How does the company plan to mitigate the high debt-to-equity ratio of 3.20 post-IPO, given that a substantial portion of proceeds is allocated to debt repayment?
What specific criteria will ABH Healthcare use to identify targets for inorganic growth, considering the current risk of 100% revenue concentration in a single facility?
18
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
